Back to companies
Prelude Therapeutics Inc
PRLDUSNASDAQPharmaceuticals & HealthcarePrelude Therapeutics Inc
Revenue
$12.1mn
YoY +73.4%
Operating income
-$104.6mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API